日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial

阿贝西利治疗伴有体细胞NF2或CDK通路改变的脑膜瘤:Alliance A071401 II期试验

Brastianos, Priscilla K; Dooley, Katharine; Geyer, Susan; Gerstner, Elizabeth R; Kaufmann, Timothy J; Iafrate, A John; Martinez-Lage, Maria; Milhem, Mohammed; Welch, Mary Roberta; Kaley, Thomas J; Drappatz, Jan; Chan, Amy; Kumthekar, Priya; Matsuoka, Carlos Kamiya; Strowd, Roy E; Cohen, Adam L; Jaeckle, Kurt; Robell, Lindsay; Magge, Rajiv S; Nam, Joo Yeon; Blondin, Nicholas; Shaikh, Nawal; Rabinowitz, Ian; Thomas, Alissa A; Piccioni, David E; Brown, Paul; Kaluziak, Stefan; Codd, Elizabeth; Cahill, Daniel P; Santagata, Sandro; Barker, Frederick G 2nd; Galanis, Evanthia

Reversible downregulation of HLA class I in adenoid cystic carcinoma

腺样囊性癌中HLA I类分子的可逆性下调

Annie Li,Bianca L Gonda,Elizabeth M Codd,Adam von Paternos,Dawn R Mitchell,Markus D Herrmann,Prinjali Kalyan,Samantha E Flynn,Thuc Q Dzu,Chengzhuo Gao,Edwin Zhang,Julia J Mendel,Julia C Thierauf,Peter M Sadow,Thomas Denize,Diane Yang,Florian J Fintelmann,Jo Anne Fordham,Ross D Merkin,Atul K Bhan,Yu-Chung Huang,Jeffrey Raizer,William C Faquin,Daniel L Faden,Xin Gao,Jong Chul Park,Lori J Wirth,Stefan T Kaluziak,A John Iafrate

Discovery of Gene Fusions in Driver-Negative Cancer Samples From the National Cancer Institute-Molecular Analysis for Therapy Choice Screening Cohort.

在国家癌症研究所分子分析治疗选择筛查队列中,发现驱动基因阴性癌症样本中的基因融合

Kaluziak Stefan T, Codd Elizabeth M, Purohit Rashi, Melli Beatrice, Kalyan Prinjali, Fordham Jo Anne, Kirkpatrick Grace, McShane Lisa M, Chang Ting-Chia, Yang Guangxiao, Wang Jinglan, Williams P Mickey, Karlovich Chris, Sklar Jeffrey, Iafrate A John

De novo transcriptome assembly for the lobster Homarus americanus and characterization of differential gene expression across nervous system tissues

美洲龙虾的从头转录组组装和神经系统组织中差异基因表达的表征

Lara Lewis McGrath, Steven V Vollmer, Stefan T Kaluziak, Joseph Ayers